May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the ...

Registration has opened for the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which will highlight advances in cancer research and clinical care involving radiation therapy. The meeting, which will be held Sept. 24–27 at the San Diego Convention Center, is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team.

Partners HealthCare and GE Healthcare announced a 10-year collaboration to rapidly develop, validate and strategically integrate deep learning technology across the entire continuum of care. The collaboration will be executed through the newly formed Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science and will feature co-located, multidisciplinary teams with broad access to data, computational infrastructure and clinical expertise.

May 17, 2017 — Tumors, inflammation and circulatory disorders locally disturb the body's acid-base balance. These ...

Seno Medical Instruments Inc. recently announced that is Imagio opto-acoustic (OA/US) breast imaging system results correlate with the histopathological findings of benign and malignant breast masses. These data were highlighted during an oral presentation at the American Roentgen Ray Society (ARRA) Annual Meeting, May 1-5 in New Orleans.

A new study of high school football players adds to mounting evidence that the Q-Collar may help reduce brain injury from sports-related head impacts.

Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be stopped in the FALCON clinical study of fluciclovine (18F) PET/CT imaging, based on successful results of a pre-planned interim analysis. The FALCON trial, announced in March 2016, is a U.K.-based, open-label study (NCT02578940) to evaluate the clinical impact of fluciclovine (18F) positron emission tomography/computed tomography (PET/CT) imaging on patient management decisions in men with biochemically recurrent prostate cancer.

Carestream Health is demonstrating new imaging analytics tools that are being added to its Clinical Collaboration Platform at the upcoming Society for Imaging Informatics in Medicine (SIIM) conference, June 1-3 in Pittsburgh. These new capabilities are designed to equip healthcare providers to deliver preventative care.

A study in 65 countries has revealed low adoption of International Atomic Energy Agency (IAEA) recommendations to reduce nuclear cardiology radiation exposure. The research was presented at ICNC 2017, May 7-9 in Vienna Austria, by Edward Hulten, M.D., a cardiologist at the Walter Reed National Military Medical Center, Bethesda, Md.